Intervention

data collection

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 13 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials13
Recruiting4
Common conditions25
Lead sponsors shown13
Advertisement

Clinical trials

13 shown
Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world StudyNCT06240195 · 2023-01-17
RECRUITING
Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in ItalyNCT07375069 · 2022-10-01
RECRUITING
Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RICNCT04528355 · 2020-08-20
RECRUITING
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma PatientsNCT02622581 · 2015-12-01
RECRUITING
Evaluation of the Utility of Rapid On-site Cytology Performed by an Interventional Pulmonologist During EBUS-TBNA.NCT07590947 · 2022-05-22
COMPLETED
A Study on Drug-drug Interactions in Patients Treated With Anticancer Agents for a Prostate Cancer in Real Life SettingNCT05612841 · 2022-04-05
UNKNOWN
HIV and Inflammatory or Autoimmune Disease: Rare Patients, Many Questions (MAIVIH)NCT05036811 · 2021-06-07
UNKNOWN
A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.NCT04760990 · 2021-02-01
COMPLETED
Bronchial Asthma and Diabetes: Impact on Bronchial Inflammation and Exercise CapacityNCT04448262 · 2019-07-10
TERMINATED
Data Acquisition Study in Inadequately Balanced Patients With Type 2 Diabetes MellitusNCT04155996 · 2019-01-20
TERMINATED
Admission of Adult-onset Still Disease Patients in the ICUNCT03276650 · 2017-09-01
COMPLETED
Optional Sub-study to Intraoperative Imaging With ICG RegistryNCT02651246 · 2015-12-01
COMPLETED
Machine and Deep Learning for Congenital Diaphragmatic Hernia (CLANNISH)NCT04609163 · 2012-01-01
COMPLETED

Common conditions

Adult-Onset Still Disease1Asthma1Breast Cancer1Cancer of Neuro-onc, Parathyroid, Desmoid Tumors, Melanoma Cancer1Cancer of the Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut), Sarcoma Cancer1Congenital Bone Marrow Failure Syndromes1Congenital Diaphragmatic Hernia1COVID-19 (Severe Coronavirus Disease 2019)1Critically Ill1Diabete Type 21Hereditary Anemias1Hiv1Inflammatory Conditions1Inherited Metabolic Disorders (IMD)1Lung Neoplasms1Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut) Cancer1Mediastinal Lymphadenopathy1Metastatic Non-small Cell Lung Cancer (NSCLC)1Multiple Sclerosis1Non Small Cell Lung Cancer Stage III1Non-small Cell Lung Cancer Metastatic1Non-small Cell Lung Cancer Stage I1Non-small Cell Lung Cancer Stage II1Primary Immunodeficiency (PID)1Prostatic Neoplasm1

Trial status mix

COMPLETED5
RECRUITING4
TERMINATED2
UNKNOWN2
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.